Courtney Shick, PA
Medical · Silverdale, WANPI 1003066432
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,530 of the $3,512 with a category attached, or 72.0%. 10 manufacturers reported payments, led by Medtronic at 58.1% of the total. Reporting peaked in 2022 at $1,757 and has fallen 95.6% since, to $78 in 2025.
Across 39 payments — averaging $90.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Axonics, Inc.$1K
- Urogen Pharma, Inc.$66
- Progenics Pharmaceuticals, Inc.$59
- Teleflex LLC$47
- Laborie Medical Technologies Corp.$44
- plus $77 from 4 others
What the payments were for
- Travel & lodging$2,53072%
- Food & beverage$95127%
- Education$311%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 20 | $2,040 |
| Axonics, Inc. | 7 | $1,180 |
| Urogen Pharma, Inc. | 2 | $66 |
| Progenics Pharmaceuticals, Inc. | 2 | $59 |
| Teleflex LLC | 2 | $47 |
| Laborie Medical Technologies Corp. | 2 | $44 |
| 180 Medical, Inc. | 1 | $34 |
| Tolmar Pharmaceuticals, Inc. | 1 | $25 |
| Myriad Genetic Laboratories, Inc. | 1 | $14 |
| Travere Therapeutics, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,512 in reported general payments places this provider in the 85th percentile of 457 medical providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 114 | $81,804 |
| MyrbetriqMirabegron | 99 | $76,622 |
| Estradiol | 74 | $4,805 |
| Trospium Chloride | 84 | $4,541 |
| Solifenacin Succinate | 61 | $4,285 |
| Tolterodine Tartrate ErTolterodine Tartrate | 30 | $1,866 |
| Tamsulosin Hcl | 148 | $1,806 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 42 | $1,185 |
| Finasteride | 62 | $1,078 |
| Cephalexin | 87 | $548 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 25 | $356 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 35 | $157 |
Paid to pharmacies, not to this prescriber.
Other medical in Silverdale
- Diana McFarlaneSeattle$95K
- Karissa SecoraTacoma$53K
- Tori FranklinLakewood$23K
- Salvador LopezYakima$17K
- Amy NelsonSeattle$15K
- Rebecca JohnsonSpokane$14K
- Jonathan CyphersBurien$13K
- Jonathan WhiteSeattle$13K
- Julia TaylorSpokane$12K
- Kristine WesselsSpokane$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.